How many drugs treat Familial Mediterranean fever?

Drug Landscape tracks 4 marketed treatments for Familial Mediterranean fever (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/familial-mediterranean-fever.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Familial Mediterranean fever — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Familial Mediterranean fever (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Familial Mediterranean fever, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Ilaris	CANAKINUMAB	Novartis Pharms	Non-Standardized Plant Allergenic Extract [EPC]	Interleukin-1 beta	2009-01-01
Anakinra	Kineret	Biovitrum Ab	Interleukin-1 Receptor Antagonist	Interleukin-1 receptor, type I	2001-01-01
Kineret	ANAKINRA	Biovitrum Ab	Interleukin-1 Receptor Antagonist [EPC]	Interleukin-1 receptor, type I	2001-01-01
Colcrys	COLCHICINE	Scilex Pharms	Alkaloid [EPC]	Serine/threonine-protein kinase pim-1	1961-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Biovitrum Ab · 2 drugs in Familial Mediterranean fever
Novartis Pharms · 1 drug in Familial Mediterranean fever
Scilex Pharms · 1 drug in Familial Mediterranean fever

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Familial Mediterranean fever:

Cite this brief

Drug Landscape (2026). Familial Mediterranean fever — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/familial-mediterranean-fever. Accessed 2026-06-10.

Familial Mediterranean fever full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing